{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:28:37Z","timestamp":1787498917910,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["359183"],"award-info":[{"award-number":["359183"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This work presents a mathematical model for the dynamics of HIV-related kidney diseases. The study examines two cases, considering the effects of the absence of treatment and the effects of Highly Active Antiretroviral Therapy (HAART) on different infection groups. Studying these cases is important because many developing countries implement HAART late, and not all HIV-infected individuals receive this therapy. Kidney diseases in HIV individuals are modeled as arising from both HIV infection itself and the use of nephrotoxic drugs. In the analysis of the mathematical model, it is shown that the state variables of the model are non-negative and bounded. Furthermore, we derived a formula for control reproduction number\n                    <jats:inline-formula>\n                      <jats:tex-math>$$R_c$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    which was used to compare the cases considered. The sensitivity analysis of the model reveals that the effect of HAART in reducing the progression from HIV to HIV-related kidney diseases is more significant compared to other effects of HAART on disease dynamics, which is also confirmed through numerical simulations. The Markov Chain Monte Carlo (MCMC) method was used to estimate parameters and evaluate the model using real data of the HIV population from Tanzania from 1990 to 2022. Numerical simulations demonstrated that while HAART reduces HIV progression to the AIDS stage, the population of individuals with HIV-related kidney diseases is increasing and is projected to continue increasing. Additionally, the results show that improving the effectiveness of HAART by 90% in preventing the progression from HIV to HIV-related kidney diseases can significantly decrease the prevalence of HIV-related kidney diseases. This study addresses a gap in understanding how population-level HAART availability influences the dynamics of HIV-related kidney disease, particularly in settings with delayed or inconsistent treatment access. By analyzing disease progression under these conditions, our findings provide insights that can inform public health strategies for improving HIV care in resource-limited settings and other contexts where access disparities persist. In addition, the work investigated scenarios related to data quality in which the model parameters can be well identified, which can serve as a guide for obtaining informative real data.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-94114-x","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:50:31Z","timestamp":1742187031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modeling the impact of antiretroviral therapy on HIV and related kidney diseases in Tanzania"],"prefix":"10.1038","volume":"15","author":[{"given":"Janeth Pancras","family":"Mchwampaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miracle","family":"Amadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyimvua Shaban","family":"Mbare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"94114_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/630503","volume":"2015","author":"H-F Huo","year":"2015","unstructured":"Huo, H.-F. & Chen, R. Stability of an HIV\/AIDS treatment model with different stages. Discret. Dyn. Nat. Soc. 2015, 630503 (2015).","journal-title":"Discret. Dyn. Nat. Soc."},{"key":"94114_CR2","doi-asserted-by":"publisher","first-page":"3105734","DOI":"10.1155\/2022\/3105734","volume":"2022","author":"SW Teklu","year":"2022","unstructured":"Teklu, S. W. & Rao, K. P. HIV\/AIDS-pneumonia codynamics model analysis with vaccination and treatment. Comput. Math. Methods Med. 2022, 3105734 (2022).","journal-title":"Comput. Math. Methods Med."},{"key":"94114_CR3","unstructured":"UNAIDS, D. Report. Retrieved February (2021)."},{"issue":"1","key":"94114_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3346\/jkms.2013.28.1.67","volume":"28","author":"SH Lee","year":"2013","unstructured":"Lee, S. H. et al. Trends of mortality and cause of death among HIV-infected patients in Korea, 1990\u20132011. J. Korean Med. Sci. 28(1), 67\u201373 (2013).","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"94114_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/jcm8081254","volume":"8","author":"G Alfano","year":"2019","unstructured":"Alfano, G. et al. Kidney disease in HIV infection. J. Clin. Med. 8(8), 1254 (2019).","journal-title":"J. Clin. Med."},{"key":"94114_CR6","unstructured":"CDC: Chronic kidney disease in the united states, 2019. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention 3 (2019)."},{"issue":"6","key":"94114_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/cid\/ciu919","volume":"60","author":"AG Abraham","year":"2015","unstructured":"Abraham, A. G. et al. End-stage renal disease among HIV-infected adults in north America. Clin. Infect. Dis. 60(6), 941\u2013949 (2015).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"94114_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.61403\/2473-5493.1050","volume":"6","author":"H Gudaz","year":"2020","unstructured":"Gudaz, H., Ogu, H. A. & Schwartz, E. J. Long-term dynamics of the kidney disease epidemic among HIV-infected individuals. Spora J. Biomath. 6(1), 52\u201360 (2020).","journal-title":"Spora J. Biomath."},{"issue":"4","key":"94114_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4314\/ajcem.v21i4.8","volume":"21","author":"M Samje","year":"2020","unstructured":"Samje, M., Youego, E., Kefeyin, T. & Lukong, H. Effects of highly active antiretroviral treatment on liver and renal functions of HIV-infected patients attending the day care clinic of the Bamenda regional hospital, Cameroon. Afr. J. Clin. Exp. Microbiol. 21(4), 318\u2013327 (2020).","journal-title":"Afr. J. Clin. Exp. Microbiol."},{"issue":"(suppl\u20132)","key":"94114_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ndt\/gfw330","volume":"32","author":"KJ Jager","year":"2017","unstructured":"Jager, K. J. & Fraser, S. D. The ascending rank of chronic kidney disease in the global burden of disease study. Nephrol. Dial. Transplant. 32((suppl\u20132)), 121\u2013128 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"94114_CR11","doi-asserted-by":"crossref","unstructured":"Mapesi, H., Kalinjuma, A. V., Ngerecha, A., Franzeck, F., Hatz, C., Tanner, M., Mayr, M., Furrer, H., Battegay, M., Letang, E., et al. Prevalence and evolution of renal impairment in people living with HIV in rural Tanzania. In: Open forum infectious diseases, vol. 5, p. 072 (Oxford University Press, 2018).","DOI":"10.1093\/ofid\/ofy072"},{"key":"94114_CR12","doi-asserted-by":"crossref","unstructured":"Kilonzo, S. B., Seiffudin, A. T., Bakshi, F. A. & Gunda, D. W. Renal dysfunction among adult patients in Mwanza, Tanzania: Prevalence, outcomes and associated factors. Tanzania J. Health Res. 18(3) (2016).","DOI":"10.4314\/thrb.v18i3.5"},{"key":"94114_CR13","doi-asserted-by":"crossref","unstructured":"Mwemezi, O., Ruggajo, P., Mngumi, J. & Furia, F. F. Renal dysfunction among HIV-infected patients on antiretroviral therapy in Dar es Salaam, Tanzania: A cross-sectional study. Int. J. Nephrol. 2020 (2020).","DOI":"10.1155\/2020\/8378947"},{"issue":"1","key":"94114_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0125-2","volume":"12","author":"RN Peck","year":"2014","unstructured":"Peck, R. N. et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: A cross-sectional study. BMC Med. 12(1), 1\u201311 (2014).","journal-title":"BMC Med."},{"key":"94114_CR15","doi-asserted-by":"crossref","unstructured":"Mwanjala, M. N., Urio, L. J. & Mtebe, M. V. Prevalence and predictors of renal dysfunction among people living with HIV on antiretroviral therapy in the southern highland of Tanzania: A hospital-based cross-sectional study. Pan Afr. Med. J. 41 (2022).","DOI":"10.11604\/pamj.2022.41.137.27025"},{"issue":"12","key":"94114_CR16","doi-asserted-by":"publisher","first-page":"0261367","DOI":"10.1371\/journal.pone.0261367","volume":"16","author":"H Mapesi","year":"2021","unstructured":"Mapesi, H. et al. Prevalence, incidence and predictors of renal impairment in persons with HIV receiving protease-inhibitors in rural tanzania. PLoS ONE 16(12), 0261367 (2021).","journal-title":"PLoS ONE"},{"issue":"4","key":"94114_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/pubmed\/fdab189","volume":"44","author":"OD Panga","year":"2022","unstructured":"Panga, O. D. et al. Prevalence, recent infection and predictors of HIV infection in fishing community along the shore of lake Victoria in Tanzania. J. Public Health 44(4), 881\u2013890 (2022).","journal-title":"J. Public Health"},{"key":"94114_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-2331-z","volume":"15","author":"DS Nsagha","year":"2015","unstructured":"Nsagha, D. S. et al. Haart, dots and renal disease of patients co-infected with HIV\/AIDS and tb in the south west region of Cameroon. BMC Public Health 15, 1\u20138 (2015).","journal-title":"BMC Public Health"},{"issue":"7","key":"94114_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/ki.2008.305","volume":"74","author":"PJ Peters","year":"2008","unstructured":"Peters, P. J. et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 74(7), 925\u2013929 (2008).","journal-title":"Kidney Int."},{"key":"94114_CR20","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s10157-019-01768-9","volume":"23","author":"L Calza","year":"2019","unstructured":"Calza, L. et al. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy. Clin. Exp. Nephrol. 23, 1272\u20131279 (2019).","journal-title":"Clin. Exp. Nephrol."},{"key":"94114_CR21","doi-asserted-by":"crossref","unstructured":"Belay, A. S., Manaye, G. A., Kebede, K. M., Abateneh, D. D. & Debebe, S. Chronic kidney disease and its predictors among highly active antiretroviral therapy na\u00efve and experienced HIV-infected individuals at the selected hospitals, southwest Ethiopia: A comparative cross-sectional study. BMJ Public Health 1(1) (2023).","DOI":"10.1136\/bmjph-2023-000235"},{"issue":"1","key":"94114_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2352-3018(15)00211-8","volume":"3","author":"A Mocroft","year":"2016","unstructured":"Mocroft, A. et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study. Lancet HIV 3(1), 23\u201332 (2016).","journal-title":"Lancet HIV"},{"issue":"1","key":"94114_CR23","first-page":"88","volume":"19","author":"TA Adedeji","year":"2019","unstructured":"Adedeji, T. A., Adebisi, S. A., Adedeji, N. O., Biliaminu, S. A. & Olanrewaju, T. O. Effects of highly active antiretroviral therapy on renal function and renal phosphate handling in African adults with advanced HIV and CKD. Infect. Disord.-Drug Targets (Formerly Curr. Drug Targets-Infect. Disord.) 19(1), 88\u2013100 (2019).","journal-title":"Infect. Disord.-Drug Targets (Formerly Curr. Drug Targets-Infect. Disord.)"},{"key":"94114_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01873-y","volume":"21","author":"L Nyende","year":"2020","unstructured":"Nyende, L., Kalyesubula, R., Sekasanvu, E. & Byakika-Kibwika, P. Prevalence of renal dysfunction among HIV infected patients receiving tenofovir at Mulago: A cross-sectional study. BMC Nephrol. 21, 1\u20136 (2020).","journal-title":"BMC Nephrol."},{"issue":"4","key":"94114_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5206\/mase\/10852","volume":"1","author":"D Hull-Nye","year":"2020","unstructured":"Hull-Nye, D., Malik, B., Keshavamurthy, R. & Schwartz, E. J. Transient dynamics of the renal disease epidemic among HIV-infected individuals. Math. Appl. Sci. Eng. 1(4), 373\u2013382 (2020).","journal-title":"Math. Appl. Sci. Eng."},{"issue":"2","key":"94114_CR26","first-page":"218","volume":"2","author":"EMD Moya","year":"2024","unstructured":"Moya, E. M. D., Rodriguez, R. A. & Pietrus, A. A mathematical model for the study of HIV\/AIDS transmission with PrEP coverage increase and parameter estimation using MCMC with a Bayesian approach. Bull. Biomath. 2(2), 218\u2013244 (2024).","journal-title":"Bull. Biomath."},{"key":"94114_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13634-020-00675-6","volume":"2020","author":"D Luengo","year":"2020","unstructured":"Luengo, D., Martino, L., Bugallo, M., Elvira, V. & S\u00e4rkk\u00e4, S. A survey of Monte Carlo methods for parameter estimation. EURASIP J. Adv. Signal Process. 2020, 1\u201362 (2020).","journal-title":"EURASIP J. Adv. Signal Process."},{"key":"94114_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1020281327116","volume":"50","author":"C Andrieu","year":"2003","unstructured":"Andrieu, C., De Freitas, N., Doucet, A. & Jordan, M. I. An introduction to MCMC for machine learning. Mach. Learn. 50, 5\u201343 (2003).","journal-title":"Mach. Learn."},{"issue":"2","key":"94114_CR29","doi-asserted-by":"publisher","first-page":"2208319","DOI":"10.55630\/j.biomath.2022.08.319","volume":"11","author":"EMD Moya","year":"2022","unstructured":"Moya, E. M. D., Rodrigues, D. S., Pietrus, A. & Severo, A. M. A mathematical model for HIV\/AIDS under pre-exposure and post-exposure prophylaxis. Biomath 11(2), 2208319\u20132208319 (2022).","journal-title":"Biomath"},{"key":"94114_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03721-2","volume":"20","author":"M Amadi","year":"2021","unstructured":"Amadi, M., Shcherbacheva, A. & Haario, H. Agent-based modelling of complex factors impacting malaria prevalence. Malar. J. 20, 1\u201315 (2021).","journal-title":"Malar. J."},{"key":"94114_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jtbi.2012.11.028","volume":"320","author":"EA Hernandez-Vargas","year":"2013","unstructured":"Hernandez-Vargas, E. A. & Middleton, R. H. Modeling the three stages in HIV infection. J. Theor. Biol. 320, 33\u201340 (2013).","journal-title":"J. Theor. Biol."},{"issue":"1","key":"94114_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jiac.2016.10.002","volume":"23","author":"K Yoshimura","year":"2017","unstructured":"Yoshimura, K. Current status of HIV\/AIDS in the art era. J. Infect. Chemother. 23(1), 12\u201316 (2017).","journal-title":"J. Infect. Chemother."},{"key":"94114_CR33","unstructured":"Rivera, J. M. & Hashmi, M. HIV nephropathy. StatPearls (2023)."},{"issue":"2","key":"94114_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.26719\/2020.26.2.143","volume":"26","author":"I Karacan","year":"2020","unstructured":"Karacan, I., Sennaroglu, B. & Vayvay, O. Analysis of life expectancy across countries using a decision tree. East. Mediterr. Health J. 26(2), 143\u2013151 (2020).","journal-title":"East. Mediterr. Health J."},{"issue":"1","key":"94114_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","volume":"73","author":"JL Marcus","year":"2016","unstructured":"Marcus, J. L. et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J. Acquire. Immune Defic. Syndr. 73(1), 39 (2016).","journal-title":"J. Acquire. Immune Defic. Syndr."},{"issue":"4","key":"94114_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1137\/S0036144500371907","volume":"42","author":"HW Hethcote","year":"2000","unstructured":"Hethcote, H. W. The mathematics of infectious diseases. SIAM Rev. 42(4), 599\u2013653 (2000).","journal-title":"SIAM Rev."},{"key":"94114_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biosystems.2018.09.002","volume":"174","author":"J Wairimu","year":"2018","unstructured":"Wairimu, J., Chirove, F., Ronoh, M. & Malonza, D. M. Modeling the effects of insecticides resistance on malaria vector control in endemic regions of Kenya. Biosystems 174, 49\u201359 (2018).","journal-title":"Biosystems"},{"issue":"1\u20132","key":"94114_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","volume":"180","author":"P Driessche","year":"2002","unstructured":"Driessche, P. & Watmough, J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180(1\u20132), 29\u201348 (2002).","journal-title":"Math. Biosci."},{"key":"94114_CR39","unstructured":"Disease Control, C. & Prevention, U. Morbidity and Mortality Weekly Report. US Department of Health, Education, and Welfare, Public Health Service."},{"key":"94114_CR40","unstructured":"UNAIDS: HIV estimates with uncertainty bounds 1990-Present. https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/HIV_estimates_with_uncertainty_bounds_1990-present. Accessed: 2023-09-30 (2023)."},{"key":"94114_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11222-006-9438-0","volume":"16","author":"H Haario","year":"2006","unstructured":"Haario, H., Laine, M., Mira, A. & Saksman, E. Dram: Efficient adaptive MCMC. Stat. Comput. 16, 339\u2013354 (2006).","journal-title":"Stat. Comput."},{"key":"94114_CR42","unstructured":"UNAIDS: The urgency of now: AIDS at a crossroads. Joint United Nations Programme on HIV\/AIDS Geneva (2024)."},{"key":"94114_CR43","unstructured":"World Health Organization: Country Cooperation Strategy: 2022-2027 - United Republic of Tanzania. https:\/\/www.afro.who.int\/sites\/default\/files\/2022-04\/CCS%20Tanzania.pdf. Accessed: 2025-02-11 (2022)."},{"key":"94114_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","volume":"41","author":"NF Crum","year":"2006","unstructured":"Crum, N. F. et al. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. JAIDS J. Acquir. Immune Defic. Syndr. 41, 194\u2013200 (2006).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"94114_CR45","doi-asserted-by":"crossref","unstructured":"Nforbugwe, A. C., Asongalem, A. E., Nchotu, B. R., Tanue, E. A., Wirsiy, F. S. & Assob, N. J. Assessment of the effect of HAART on renal function of HIV patients attending the Bamenda regional hospital, Cameroon. Open AIDS J. 14(1) (2020).","DOI":"10.2174\/1874613602014010001"},{"key":"94114_CR46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4103\/ijdvl.IJDVL_169_18","volume":"86","author":"VK Mahajan","year":"2020","unstructured":"Mahajan, V. K. et al. Assessment of liver and renal functions in human immunodeficiency virus-infected persons on highly active antiretroviral therapy: A mixed cohort study. Indian J. Dermatol. Venereol. Leprol. 86, 499 (2020).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"5","key":"94114_CR47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s11538-008-9299-0","volume":"70","author":"N Chitnis","year":"2008","unstructured":"Chitnis, N., Hyman, J. M. & Cushing, J. M. Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model. Bull. Math. Biol. 70(5), 1272\u20131296 (2008).","journal-title":"Bull. Math. Biol."},{"key":"94114_CR48","doi-asserted-by":"crossref","unstructured":"Omame, A., Han, Q., Iyaniwura, S. A., Ebenezer, A., Bragazzi, N. L., Wang, X., Kong, J. D. & Woldegerima, W. A. Understanding the impact of HIV on MPOX transmission in an MSM population: A mathematical modeling study. Infect. Dis. Modell. (2024).","DOI":"10.2139\/ssrn.4793888"},{"issue":"11","key":"94114_CR49","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/QAD.0b013e328348a4b1","volume":"25","author":"L Msango","year":"2011","unstructured":"Msango, L. et al. Renal dysfunction among HIV-infected patients starting antiretroviral therapy in Mwanza, Tanzania. AIDS 25(11), 1421 (2011).","journal-title":"AIDS"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94114-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:50:39Z","timestamp":1742187039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94114-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94114"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94114-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No competing interests exist in the submission of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9094"}}